Join John Kitchens, MD, and Michael Klufas, MD, to review pearls and data on the efficacy of next-generation anti-vascular endothelial growth factor (VEGF) drugs.

Watch the full episode here: https://eyesoneyecare.com/resources/decreasing-treatment-burdens-with-second-generation-anti-vegf-agents/

Retina Mentor Moments is independently editorial content supported by advertising from Regeneron. The information provided in this article does not and is not intended to constitute medical advice; instead, all information, content, materials available herein are for general information purposes only.

Retina Mentor Moments is independently editorial content supported by advertising from Regeneron. The information provided in this article does not and is not intended to constitute medical advice; instead, all information, content, materials available herein are for general information purposes only.